Skip to main content
Figure 2 | Translational Neurodegeneration

Figure 2

From: The efficacy and safety of pramipexole ER versus IR in Chinese patients with Parkinson’s disease: a randomized, double-blind, double-dummy, parallel-group study

Figure 2

Reduction of ‘off’-time in advanced PD patients. (A) Adjusted mean change in the percentage of ‘off’-time over time in patients with advanced Parkinson disease (PD), full analysis set (FAS) (last observation carried forward, LOCF); (B) Adjusted mean duration (±SE) of ‘off’-time. For A and B: No difference was observed in the adjusted mean percentage ‘off’-time or duration between the two arms at any study visit (ANCOVA).

Back to article page